STOCK TITAN

Orix SEC Filings

IX NYSE

Welcome to our dedicated page for Orix SEC filings (Ticker: IX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

ORIX Corporation (IX) filings document the disclosures of a foreign private issuer with American depositary shares listed on the NYSE. Its Form 20-F annual reports and Form 6-K current reports cover consolidated operating and financial results, U.S. GAAP reporting, audited financial statements, dividends, share repurchases, and the capital structure of the Japanese parent company.

ORIX's current reports also record governance and corporate-organization matters, including management changes, board and committee composition, amendments to articles of incorporation, and business-unit reforms. Material-event filings describe subsidiary and portfolio actions across banking, private equity, infrastructure, real estate and other financial-services activities, along with extraordinary-report disclosures tied to those corporate events.

Rhea-AI Summary

ORIX Corporation disclosed a share repurchase program allowing purchases of common shares up to 100 billion yen executed via market purchases under a discretionary dealing contract. The buyback window runs from May 19, 2025 to March 31, 2026. The report shows 21,059,600 shares were repurchased for a total of JPY 71,679,526,500.

The filing lists the method as market purchases based on a discretionary dealing contract and specifies the maximum authorized amount and the precise executed share count and yen value recorded in the report.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

ORIX (through OFI-01 Corporation) has launched a tender offer to acquire all outstanding common shares of I-NET Corp. (TSE: 9600) at JPY 2,530 per share, with a purchase target of 15,257,622 shares and a minimum acceptance threshold of 10,171,800 shares (66.67%). The total purchase price at full acceptance is JPY 38,601 million and the tender period runs from October 3, 2025 to November 17, 2025. I-NET's board has expressed its opinion in support of the Tender Offer and recommended shareholders tender their shares. The Offeror intends to make I-NET a wholly owned subsidiary and pursue "Two-Step Acquisition" squeeze-out procedures if minimum conditions are met. Multiple prior price proposals and requests for reconsideration are disclosed, showing a final agreed price of JPY 2,530 subject to the Target's board approval. The filing also discloses projected free cash flow of negative JPY 1.303 billion for fiscal 2026 and positive JPY 2.132 billion for fiscal 2027, and notes the Business Plan does not reflect any synergies from the Tender Offer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

ORIX Corporation reports a restricted-share issuance under an employee plan with a disposal price of ¥3,882 per share and a total contribution of ¥552,796,800. The filing states the paid-in amount from the contributions will not be incorporated into capital. The document lists two participant counts as "234 Persons" and "84 Persons" and describes the consideration as in-kind contributions of the Monetary Grant held by Eligible Employees, which will be provided by the company or its subsidiaries for the Restricted Shares. The filing provides basic transaction values and participant counts but does not include further detail on allocation, vesting, or impact on outstanding share count.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

ORIX Corporation filed a Form 6-K as a foreign private issuer, primarily to add new exhibits to its existing shelf registration on Form F-3. The filing incorporates these materials by reference into the related prospectus.

The exhibits include the form of Global Note for ORIX’s 4.450% Notes due 2030, along with legal opinions from Mitsui Company and Davis Polk & Wardwell LLP and their related consents. The report is signed on behalf of ORIX by Yasuaki Mikami, a board member and Senior Managing Executive Officer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

ORIX Corporation disclosed a share repurchase program in an American current report. The company authorized repurchases of common shares up to 100 billion yen, with purchases to occur from May 19, 2025 through March 31, 2026. Under a market purchase arrangement based on a discretionary dealing contract, ORIX bought 17,626,200 shares for a total of JPY 58,252,180,900. The filing specifies the authorization limit, the authorized period, the method (market purchases under a discretionary contract) and the actual repurchased amount and cost.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

ORIX Corporation filed a prospectus supplement describing its debt securities offering and recent business and financial trends. For the three months ended June 30, 2025, total revenues reached (reported as in the filing) with a year-on-year increase of 9%. Operating income grew 29% to and income before income taxes rose 34.4% year-on-year. Net income attributable to ORIX shareholders for the period increased 24% to and basic earnings per share rose to (an increase of 26%).

Total assets were reported at and total ORIX shareholders' equity at , producing a shareholders' equity ratio of 24.4%. The debt-to-equity ratio including deposits remained near 2.1x-2.2x. The supplement discloses (i) ORIX Corporation USA's prior acquisition of Boston Capital's LIHTC portfolio and (ii) a pending agreement for ORIX Corporation USA to acquire a majority stake in Hilco Global, subject to regulatory approvals. The prospectus also details Japanese tax withholding rules applicable to non-resident holders and customary lender collateral and offset rights.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.95%
Tags
prospectus
Rhea-AI Summary

ORIX Corp filed a Form 13F disclosing institutional holdings with a reported Form 13F information table value of $249,276,210 and 1 table entry. The filing is a 13F Combination Report signed by Stan Koyanagi on 08-13-2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Overview: OPI18 Corporation, a subsidiary of ORIX Corporation, conducted a tender offer for Ascentech K.K. (TSE: 3565) from June 17, 2025 to August 4, 2025 at JPY 1,680 per share. The Offeror set a minimum purchase condition of 9,546,000 shares and a maximum of 14,318,978 shares.

Result: A total of 9,259,301 shares were tendered, which did not meet the minimum threshold, and therefore the Offeror will not purchase any Tendered Shares. Public notice of the results was made at the Tokyo Stock Exchange on August 5, 2025. Tendered share records will be reverted on August 6, 2025. Further details are available in the Offeror's separate notice dated August 5, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many Orix (IX) SEC filings are available on StockTitan?

StockTitan tracks 77 SEC filings for Orix (IX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Orix (IX)?

The most recent SEC filing for Orix (IX) was filed on October 3, 2025.